Found: 40
Select item for more details and to access through your institution.
World's first TIL therapy approved.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 349, doi. 10.1038/s41587-024-02195-2
- Publication type:
- Article
Growing community across the C-suite.
- Published in:
- 2024
- Publication type:
- Editorial
US bill targets Chinese biotechs.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 353, doi. 10.1038/s41587-024-02191-6
- Publication type:
- Article
In vivo CRISPR agent cuts HAE attacks 95%.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 352, doi. 10.1038/s41587-024-02188-1
- Publication type:
- Article
A synthetic antibiotic overcomes antimicrobial resistance.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 379, doi. 10.1038/s41587-024-02185-4
- By:
- Publication type:
- Article
Supercharging T cell therapy with cancer mutations.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 379, doi. 10.1038/s41587-024-02184-5
- By:
- Publication type:
- Article
Predicting the structure of large protein complexes.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 379, doi. 10.1038/s41587-024-02183-6
- By:
- Publication type:
- Article
Cell-based coffee future-proofs world's favorite brew.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 350, doi. 10.1038/s41587-024-02181-8
- By:
- Publication type:
- Article
Innovators want pills to treat sickle cell disease. Can they match gene therapy?
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 347, doi. 10.1038/s41587-024-02179-2
- By:
- Publication type:
- Article
Biotech news from around the world.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 354, doi. 10.1038/s41587-024-02177-4
- Publication type:
- Article
After obesity drugs' success, companies rush to preserve skeletal muscle.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 351, doi. 10.1038/s41587-024-02176-5
- By:
- Publication type:
- Article
Lighting the match: how a student-led career mentorship program can blaze the way for non-academic careers.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 530, doi. 10.1038/s41587-024-02170-x
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 536, doi. 10.1038/s41587-024-02169-4
- Publication type:
- Article
Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 406, doi. 10.1038/s41587-023-02096-w
- By:
- Publication type:
- Article
2H23 biotech job picture.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 535, doi. 10.1038/s41587-024-02167-6
- By:
- Publication type:
- Article
RNA interference in the era of nucleic acid therapeutics.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 394, doi. 10.1038/s41587-023-02105-y
- By:
- Publication type:
- Article
Wearable technology and devices.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 378, doi. 10.1038/s41587-024-02163-w
- Publication type:
- Article
Author Correction: Predicting the efficiency of prime editing guide RNAs in human cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Cancer-targeting antibody–drug conjugates drive dealmaking frenzy.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 362, doi. 10.1038/s41587-024-02168-5
- By:
- Publication type:
- Article
Hypoimmune cells resist rejection in monkeys.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 380, doi. 10.1038/s41587-023-02013-1
- By:
- Publication type:
- Article
Fresh from the biotech pipeline: record-breaking FDA approvals.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 355, doi. 10.1038/s41587-024-02166-7
- By:
- Publication type:
- Article
The perpetual motion machine of AI-generated data and the distraction of ChatGPT as a 'scientist'.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Wearable ultrasound for continuous deep-tissue monitoring.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 386, doi. 10.1038/s41587-023-02098-8
- By:
- Publication type:
- Article
Biologic patent challenges under the America Invents Act.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 374, doi. 10.1038/s41587-024-02156-9
- By:
- Publication type:
- Article
Cancer variant modeling in vivo.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 383, doi. 10.1038/s41587-023-02080-4
- By:
- Publication type:
- Article
Scalable, accessible and reproducible reference genome assembly and evaluation in Galaxy.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Generation of precision preclinical cancer models using regulated in vivo base editing.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 437, doi. 10.1038/s41587-023-01900-x
- By:
- Publication type:
- Article
Author Correction: An engineered influenza virus to deliver antigens for lung cancer vaccination.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Inferring cell–cell communication at single-cell resolution.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 390, doi. 10.1038/s41587-023-01834-4
- Publication type:
- Article
Selection by essential-gene exon knock-in for the generation of efficient cell therapies.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 388, doi. 10.1038/s41587-023-01819-3
- Publication type:
- Article
CRISPR-free, strand-selective mitochondrial DNA base editing using a nickase.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 392, doi. 10.1038/s41587-023-01820-w
- Publication type:
- Article
A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 424, doi. 10.1038/s41587-023-01783-y
- By:
- Publication type:
- Article
A fully integrated wearable ultrasound system to monitor deep tissues in moving subjects.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 448, doi. 10.1038/s41587-023-01800-0
- By:
- Publication type:
- Article
An engineered influenza virus to deliver antigens for lung cancer vaccination.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 518, doi. 10.1038/s41587-023-01796-7
- By:
- Publication type:
- Article
Deep learning models to predict the editing efficiencies and outcomes of diverse base editors.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 484, doi. 10.1038/s41587-023-01792-x
- By:
- Publication type:
- Article
Strand-selective base editing of human mitochondrial DNA using mitoBEs.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 498, doi. 10.1038/s41587-023-01791-y
- By:
- Publication type:
- Article
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 413, doi. 10.1038/s41587-023-01784-x
- By:
- Publication type:
- Article
Comparative analysis of cell–cell communication at single-cell resolution.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 470, doi. 10.1038/s41587-023-01782-z
- By:
- Publication type:
- Article
A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 510, doi. 10.1038/s41587-023-01774-z
- By:
- Publication type:
- Article
A highly efficient transgene knock-in technology in clinically relevant cell types.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 3, p. 458, doi. 10.1038/s41587-023-01779-8
- By:
- Publication type:
- Article